The Janssen results aren't far off either; Q3 of this FY so we have news scheduled for some time in Jan to Mar 2020. If things go well our revenue pipeline will be fasttracked and no doubt the SP will rerate. In the mean time there are a number of positive developments that can pop up at any time like a US distribution partner, and the ramping of revenue from the current licensees. Guardia is a wildcard, I think there's more there than they are telling us. Why suspend endometriosis and not guardia? Would have thought Endometriosis to be the more important from a market perspective so I'm thinking that validation for Guardia is all but a foregone conclusion... or am I just contra-conspiracy nutjob?
- Forums
- ASX - By Stock
- Ann: Appendix 4C - September 2019 Quarterly Report
The Janssen results aren't far off either; Q3 of this FY so we...
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PIQ (ASX) to my watchlist
|
|||||
Last
63.0¢ |
Change
-0.070(10.0%) |
Mkt cap ! $82.53M |
Open | High | Low | Value | Volume |
70.5¢ | 71.0¢ | 60.0¢ | $882.4K | 1.345M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 62.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
63.0¢ | 3952 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 0.625 |
2 | 19129 | 0.620 |
2 | 2170 | 0.615 |
2 | 104000 | 0.610 |
1 | 13500 | 0.605 |
Price($) | Vol. | No. |
---|---|---|
0.630 | 3952 | 1 |
0.635 | 75122 | 2 |
0.640 | 2528 | 1 |
0.650 | 9298 | 1 |
0.655 | 2464 | 1 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |